Article Information
History
- February 2, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Kathryn Davidson1,†,
- Paul Grevitt1,†,
- Maria F. Contreras G.1,
- Katherine S. Bridge2,
- Miguel Hermida3,
- Kunal M. Shah1,
- Faraz K Mardakheh1,
- Mark Stubbs4,
- Paul A. Clarke4,
- Rosemary Burke4,
- Pedro Casado-Izquierdo1,
- Pedro R. Cutillas1,
- Sarah A. Martin1,* and
- Tyson V. Sharp1,*
- 1Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ
- 2University of York, Wentworth Way, York, YO10 5DD
- 3Department of Bioengineering, Imperial College, London
- 4Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, 15 Cotswold Road, Sutton, SM2 5NG
- ↵*Corresponding Authors: t.sharp{at}qmul.ac.uk, sarah.martin{at}qmul.ac.uk
↵† These authors contribute equally.